DUBLIN--(BUSINESS WIRE)--The "Partnerships, Licensing, Investments and M&A Deals and Trends for July 2019 in Pharmaceuticals" report has been added to ResearchAndMarkets.com's offering.
Partnerships, Licensing, Investments and M&A Deals and Trends for July 2019 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2019.
The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Pharmaceuticals & Healthcare, Global, Deal Summary
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, July 2019
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, July 2019
2.2.1 Gilead Sciences and Galapagos to Enter into R&D Agreement
2.2.2 Merck Raises USD909.31 Million in Private Placement of Bonds
2.2.3 Genentech Enters into Licensing Agreement with Skyhawk Therapeutics
2.2.4 Boehringer Ingelheim Enters into Licensing Agreement with Bridge Biotherapeutics
2.2.5 Genentech Enters into Licensing Agreement with Sosei Heptares
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, July 2019
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, July 2019
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
3.1 Pharmaceuticals & Healthcare, Global, M&A, July 2019
3.1.1 Top M&A Deals in July 2019
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, February 2019 - July 2019
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, July 2019
3.2.1 Top Equity Offering Deals in July 2019
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, February 2019 - July 2019
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, July 2019
3.3.1 Top PE/VC Deals in July 2019
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, July 2019
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, July 2019
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2016-July 2019
3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2016-July 2019
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, July 2019
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, February 2019 - July 2019
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), July 2019
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, July 2019
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, February 2019 - July 2019
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), February 2019 - July 2019
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), February 2019 - July 2019
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, July 2019
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, July 2019
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2019
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), February 2019 - July 2019
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), February 2019 - July 2019
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), February 2019 - July 2019
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), February 2019 - July 2019
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, July 2019
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, July 2019
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, July 2019
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, July 2019
5.1.1 Oncology - Deals of the Month
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, July 2019
5.2.1 Central Nervous System - Deals of the Month
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, July 2019
5.3.1 Infectious Diseases - Deals of the Month
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, July 2019
5.4.1 Cardiovascular - Deals of the Month
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, July 2019
5.5.1 Immunology - Deal of the Month
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, July 2019
5.6.1 Gastrointestinal - Deals of the Month
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, July 2019
5.7.1 Metabolic Disorders - Deals of the Month
6 Deal Summary by Geography
6.1 Pharmaceuticals & Healthcare, North America Deals, July 2019
6.1.1 North America - Deals of the Month
6.2 Pharmaceuticals & Healthcare, Europe, Deals, July 2019
6.2.1 Europe - Deals of the Month
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, July 2019
6.3.1 Asia-Pacific - Deals of the Month
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, July 2019
6.4.1 Rest of the World - Deals of the Month
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, February 2019 - July 2019
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, February 2019 - July 2019
8 Further Information
For more information about this report visit https://www.researchandmarkets.com/r/tl5h3p
